Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy-Reference-Cited by-同舟云学术

Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy

Published:2012-07-19 Issue:2 Volume:41 Page:270-274
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Dickmann Leslie J,Isoherranen Nina

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference34 articles.

1. Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics

2. Effects of Interleukin-6 (IL-6) and an Anti-IL-6 Monoclonal Antibody on Drug-Metabolizing Enzymes in Human Hepatocyte Culture

3. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450;Erickson;Drug Metab Dispos,1999

4. Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers

5. Pharmacokinetics of Sertraline Across Pregnancy and Postpartum

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes;Frontiers in Pharmacology;2024-08-07

2. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

3. Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications;Basic & Clinical Pharmacology & Toxicology;2024-01-15

4. Treating Neonatal Abstinence Syndrome in the Newborn;Principles of Neonatology;2024

5. A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons;Frontiers in Medicine;2023-11-29